Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (351-360 of 508) with videos related to

Pageof 51
Sort By:
Lancet (London, England)|October 10, 2022
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trialIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Neurological Research and Practice|December 16, 2020
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trialBenedikt M Frey, Florent Boutitie, Bastian Cheng, et al.
JACC. Cardiovascular Imaging|July 23, 2018
Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological InsightsCaroline Haig, David Carrick, Jaclyn Carberry, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2020
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled TrialMiles D Witham, Jennifer S Lees, Myra White, et al.
Current Controlled Trials in Cardiovascular Medicine|July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline CharacteristicsIan Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Clinical Kidney Journal|May 7, 2021
The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trialSharlene A Greenwood, Pelagia Koufaki, Jamie Macdonald, et al.
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
Plos One|June 6, 2012
Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapyDov Shiffman, Stella Trompet, Judy Z Louie, et al.
Lancet (London, England)|May 27, 2008
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesNaveed Sattar, Alex McConnachie, A Gerald Shaper, et al.
European Heart Journal|February 17, 2017
Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) StudyAnvesha Singh, John P Greenwood, Colin Berry, et al.
Pageof 51

Showing results (351-360 of 508) with videos related to

Sort By:
Pageof 51
Lancet (London, England)|October 10, 2022
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trialIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Neurological Research and Practice|December 16, 2020
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trialBenedikt M Frey, Florent Boutitie, Bastian Cheng, et al.
JACC. Cardiovascular Imaging|July 23, 2018
Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological InsightsCaroline Haig, David Carrick, Jaclyn Carberry, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2020
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled TrialMiles D Witham, Jennifer S Lees, Myra White, et al.
Current Controlled Trials in Cardiovascular Medicine|July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline CharacteristicsIan Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Clinical Kidney Journal|May 7, 2021
The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trialSharlene A Greenwood, Pelagia Koufaki, Jamie Macdonald, et al.
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
Plos One|June 6, 2012
Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapyDov Shiffman, Stella Trompet, Judy Z Louie, et al.
Lancet (London, England)|May 27, 2008
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesNaveed Sattar, Alex McConnachie, A Gerald Shaper, et al.
European Heart Journal|February 17, 2017
Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) StudyAnvesha Singh, John P Greenwood, Colin Berry, et al.
Pageof 51